Wave Life Sciences’ (WVE) RNA obesity drug WVE-007 shows potential to match GLP-1 efficacy without muscle loss

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the low priced stocks to buy with high upside potential. On December 8, Wave ...